2022
DOI: 10.1016/j.chemosphere.2022.135931
|View full text |Cite
|
Sign up to set email alerts
|

Physiologically-based toxicokinetic modeling of human dermal exposure to diethyl phthalate: Application to health risk assessment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 54 publications
0
0
0
Order By: Relevance
“…In the drug review process conducted by the United States Food and Drug Administration (FDA), submitted PBTK models from drug developers were assessed for adequacy at different stages of drug development to achieve desired objectives. Previous studies had solely focused on developing rat-based PBTK models to assess risks associated with oral exposure to diethyl phthalate (DEP), and Hu et al [5] developed a human dermal pathway-specific model for assessing health risks when exposed to DEP, which suggested that dermal exposure to DEP posed a greater risk to human health compared with oral exposure.…”
Section: Introductionmentioning
confidence: 99%
“…In the drug review process conducted by the United States Food and Drug Administration (FDA), submitted PBTK models from drug developers were assessed for adequacy at different stages of drug development to achieve desired objectives. Previous studies had solely focused on developing rat-based PBTK models to assess risks associated with oral exposure to diethyl phthalate (DEP), and Hu et al [5] developed a human dermal pathway-specific model for assessing health risks when exposed to DEP, which suggested that dermal exposure to DEP posed a greater risk to human health compared with oral exposure.…”
Section: Introductionmentioning
confidence: 99%